BenQ Medical Technology and Brain Navi Align Partnership to Advance Neurosurgical Robotics in China

Enhancing Precision and Innovation in Neurosurgical Robotics Across China

ZHUBEI,March 20, 2025/PRNewswire/ -- Brain Navi Biotechnology, a leading innovator in neurosurgical robotics, has announced a strategic partnership with BenQ Medical Technology to introduce and commercialize the NaoTrac neurosurgical navigation robot in the Chinese market. This collaboration aligns withBrain Navi's2025 globalization strategy, prioritizing localized partnerships to accelerate market entry and enhance clinical adoption.

China'ssurgical robotics industry is experiencing rapid growth. According to Frost& Sullivan market research, the surgical robot market size is projected to exceedUSD 3 billionby 2026 and reachUSD 9.5 billion by 2030. As the demand for neurosurgical precision and automation increases,Brain Navi'sNaoTrac, a cutting-edge AI-powered navigation system, will play a crucial role in enhancing patient outcomes in neurosurgery.

Through this partnership, BenQ Medical Technology will leverage its extensive hospital network acrossChinato facilitate NaoTrac's clinical deployment. This collaboration is further supported byChina's14th Five-Year Plan for the Development of the Medical Equipment Industry, which aims to foster domestic innovation and promote intelligent medical solutions.

"This collaboration marks BenQ Medical Technology as a key step in integrating surgical robots and expanding applications in smart operating rooms,"saidMichael Kuan, the President of BenQ Medical Technology. "With the rapid advancements in AI and robotic technology, intelligent healthcare is the future. Working withBrain Navi, we are committed to driving the adoption of surgical robotics inChina, providing patients with precise, safe, and innovative solutions."

Dr.Jerry Chen, CEO ofBrain Navi, emphasized the importance of regional partnerships, stating,"NaoTrac has been used in some medical centers acrossAsia,Latin America, andEurope. Partnering with BenQ Medical Technology gives us a robust gateway into the Chinese market, where localization is key to success. By combining our AI-driven surgical technology with BenQ Medical Technology's strong market presence, we are confident in accelerating the adoption of neurosurgical robotics inChina."

As part of its 2025 strategy,Brain Navicontinues to expand its global footprint, with current key focus areas in EMEA, theAsia-Pacificregion, andLatin America. The company is committed to providing localized support through distributor empowerment, hospital collaborations, and advanced training programs tailored to the needs of neurosurgeons worldwide. By fostering strong alliances with distributors and hospital networks, the company ensures the seamless integration of neurosurgical robotics into regional healthcare systems.

Brain Naviwill present NaoTrac at the AANS (American Association of Neurological Surgeons) Annual Meeting, scheduled for April 25–28, 2025, inBoston, MA.This event will offer distributors, hospitals, and neurosurgeons a chance to experience the future of neurosurgical robotics firsthand.

About BenQ Medical Technology

BenQ Medical Technology, a subsidiary of BenQ Group, is a leading provider of advanced medical devices and healthcare solutions. Founded in 1989 and headquartered inTaiwan, the company specializes in surgical equipment, imaging systems, and patient care solutions. With global certifications like ISO 13485 and ISO 9001, BenQ Medical ensures high-quality standards in medical technology. Through innovation and strategic partnerships, the company continues to expand its footprint, delivering intelligent healthcare solutions that enhance patient care and surgical precision worldwide. For more information, visitwww.benqmedicaltech.com

AboutBrain Navi:

Brain Navi Biotechnology, a leading Taiwanese surgical robotic company, specializes in designing and developing innovative navigation and robotic surgery technologies. Their proprietary Surface Mapping Auto-Registration Technology (SMART) represents a significant surgical breakthrough, integrating machine vision, robotics, and AI for streamlined surgical procedures and real-time imaging, ensuring minimal invasive outcomes. NaoTrac's swift patient registration and automatic surgical instrument registration enable surgeons to plan trajectories effortlessly, and the robot ensures precise autonomous navigation toward the desired target.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/benq-medical-technology-and-brain-navi-align-partnership-to-advance-neurosurgical-robotics-in-china-302406594.html

SOURCEBrain Navi